Global Biopharmaceutical CMO & CRO Market 2018 by Manufacturers, Countries, Type and Application, Forecast to 2023

  • receipt Report ID : 139934
  • calendar_today Published On: Jan, 2019
  • file_copy Pages: 138
  • list Business Services

A contract manufacturing organization (CMO), sometimes called a contract development and manufacturing organization (CDMO), is a company that serves other companies in the pharmaceutical industry on a contract basis to provide comprehensive services from drug development through drug manufacturing. A contract research organization (CRO) is an organization that provides support to the pharmaceutical, biotechnology, and medical device industries in the form of research services outsourced on a contract basis.

Scope of the Report:

This report studies the Biopharmaceutical CMO & CRO market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Biopharmaceutical CMO & CRO market by product type and applications/end industries.

U.S is estimated to have the largest number of biomanufacturing facilities, which in turn, has resulted in the largest share of North America region. Moreover, presence of effective regulatory bodies to monitor the overall biopharmaceutical development process to ensure the product safety and efficacy is driving the regional market of North America.

The global Biopharmaceutical CMO & CRO market is valued at xx million USD in 2017 and is expected to reach xx million USD by the end of 2023, growing at a CAGR of xx% between 2017 and 2023.

The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.

North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Biopharmaceutical CMO & CRO.

Europe also play important roles in global market, with market size of xx million USD in 2017 and will be xx million USD in 2023, with a CAGR of xx%.

Market Segment by Companies, this report covers

Lonza

Boehringer Ingelheim GmbH

Rentschler Biotechnologie GmbH

Inno Biologics Sdn Bhd

JRS Pharma

BIOMEVA GmbH

ProBioGen

FUJIFILM Diosynth Biotechnologies U.S.A., Inc.

TOYOBO CO., LTD

Samsung BioLogics

Patheon

CMC Biologics

Binex Co., Ltd.

AbbVie Inc.

WuXi Biologics

Market Segment by Regions, regional analysis covers

North America (United States, Canada and Mexico)

Europe (Germany, France, UK, Russia and Italy)

Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

South America (Brazil, Argentina, Colombia)

Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers

Mammalian

Non-mammalian

Market Segment by Applications, can be divided into

Contract Manufacturing

Contract Research

Frequently Asked Questions

The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.

Market is segmented on the basis:

  • By Type
  • By Application
  • By Region
  • By Country
  • By Manufacturer

The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.

The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.

Table of Contents

1 Biopharmaceutical CMO & CRO Market Overview

1.1 Product Overview and Scope of Biopharmaceutical CMO & CRO

1.2 Classification of Biopharmaceutical CMO & CRO by Types

1.2.1 Global Biopharmaceutical CMO & CRO Revenue Comparison by Types (2017-2023)

1.2.2 Global Biopharmaceutical CMO & CRO Revenue Market Share by Types in 2017

1.2.3 Mammalian

1.2.4 Non-mammalian

1.3 Global Biopharmaceutical CMO & CRO Market by Application

1.3.1 Global Biopharmaceutical CMO & CRO Market Size and Market Share Comparison by Applications (2013-2023)

1.3.2 Contract Manufacturing

1.3.3 Contract Research

1.4 Global Biopharmaceutical CMO & CRO Market by Regions

1.4.1 Global Biopharmaceutical CMO & CRO Market Size (Million USD) Comparison by Regions (2013-2023)

1.4.1 North America (USA, Canada and Mexico) Biopharmaceutical CMO & CRO Status and Prospect (2013-2023)

1.4.2 Europe (Germany, France, UK, Russia and Italy) Biopharmaceutical CMO & CRO Status and Prospect (2013-2023)

1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Biopharmaceutical CMO & CRO Status and Prospect (2013-2023)

1.4.4 South America (Brazil, Argentina, Colombia) Biopharmaceutical CMO & CRO Status and Prospect (2013-2023)

1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Biopharmaceutical CMO & CRO Status and Prospect (2013-2023)

1.5 Global Market Size of Biopharmaceutical CMO & CRO (2013-2023)

2 Manufacturers Profiles

2.1 Lonza

2.1.1 Business Overview

2.1.2 Biopharmaceutical CMO & CRO Type and Applications

2.1.2.1 Product A

2.1.2.2 Product B

2.1.3 Lonza Biopharmaceutical CMO & CRO Revenue, Gross Margin and Market Share (2016-2017)

2.2 Boehringer Ingelheim GmbH

2.2.1 Business Overview

2.2.2 Biopharmaceutical CMO & CRO Type and Applications

2.2.2.1 Product A

2.2.2.2 Product B

2.2.3 Boehringer Ingelheim GmbH Biopharmaceutical CMO & CRO Revenue, Gross Margin and Market Share (2016-2017)

2.3 Rentschler Biotechnologie GmbH

2.3.1 Business Overview

2.3.2 Biopharmaceutical CMO & CRO Type and Applications

2.3.2.1 Product A

2.3.2.2 Product B

2.3.3 Rentschler Biotechnologie GmbH Biopharmaceutical CMO & CRO Revenue, Gross Margin and Market Share (2016-2017)

2.4 Inno Biologics Sdn Bhd

2.4.1 Business Overview

2.4.2 Biopharmaceutical CMO & CRO Type and Applications

2.4.2.1 Product A

2.4.2.2 Product B

2.4.3 Inno Biologics Sdn Bhd Biopharmaceutical CMO & CRO Revenue, Gross Margin and Market Share (2016-2017)

2.5 JRS Pharma

2.5.1 Business Overview

2.5.2 Biopharmaceutical CMO & CRO Type and Applications

2.5.2.1 Product A

2.5.2.2 Product B

2.5.3 JRS Pharma Biopharmaceutical CMO & CRO Revenue, Gross Margin and Market Share (2016-2017)

2.6 BIOMEVA GmbH

2.6.1 Business Overview

2.6.2 Biopharmaceutical CMO & CRO Type and Applications

2.6.2.1 Product A

2.6.2.2 Product B

2.6.3 BIOMEVA GmbH Biopharmaceutical CMO & CRO Revenue, Gross Margin and Market Share (2016-2017)

2.7 ProBioGen

2.7.1 Business Overview

2.7.2 Biopharmaceutical CMO & CRO Type and Applications

2.7.2.1 Product A

2.7.2.2 Product B

2.7.3 ProBioGen Biopharmaceutical CMO & CRO Revenue, Gross Margin and Market Share (2016-2017)

2.8 FUJIFILM Diosynth Biotechnologies U.S.A., Inc.

2.8.1 Business Overview

2.8.2 Biopharmaceutical CMO & CRO Type and Applications

2.8.2.1 Product A

2.8.2.2 Product B

2.8.3 FUJIFILM Diosynth Biotechnologies U.S.A., Inc. Biopharmaceutical CMO & CRO Revenue, Gross Margin and Market Share (2016-2017)

2.9 TOYOBO CO., LTD

2.9.1 Business Overview

2.9.2 Biopharmaceutical CMO & CRO Type and Applications

2.9.2.1 Product A

2.9.2.2 Product B

2.9.3 TOYOBO CO., LTD Biopharmaceutical CMO & CRO Revenue, Gross Margin and Market Share (2016-2017)

2.10 Samsung BioLogics

2.10.1 Business Overview

2.10.2 Biopharmaceutical CMO & CRO Type and Applications

2.10.2.1 Product A

2.10.2.2 Product B

2.10.3 Samsung BioLogics Biopharmaceutical CMO & CRO Revenue, Gross Margin and Market Share (2016-2017)

2.11 Patheon

2.11.1 Business Overview

2.11.2 Biopharmaceutical CMO & CRO Type and Applications

2.11.2.1 Product A

2.11.2.2 Product B

2.11.3 Patheon Biopharmaceutical CMO & CRO Revenue, Gross Margin and Market Share (2016-2017)

2.12 CMC Biologics

2.12.1 Business Overview

2.12.2 Biopharmaceutical CMO & CRO Type and Applications

2.12.2.1 Product A

2.12.2.2 Product B

2.12.3 CMC Biologics Biopharmaceutical CMO & CRO Revenue, Gross Margin and Market Share (2016-2017)

2.13 Binex Co., Ltd.

2.13.1 Business Overview

2.13.2 Biopharmaceutical CMO & CRO Type and Applications

2.13.2.1 Product A

2.13.2.2 Product B

2.13.3 Binex Co., Ltd. Biopharmaceutical CMO & CRO Revenue, Gross Margin and Market Share (2016-2017)

2.14 AbbVie Inc.

2.14.1 Business Overview

2.14.2 Biopharmaceutical CMO & CRO Type and Applications

2.14.2.1 Product A

2.14.2.2 Product B

2.14.3 AbbVie Inc. Biopharmaceutical CMO & CRO Revenue, Gross Margin and Market Share (2016-2017)

2.15 WuXi Biologics

2.15.1 Business Overview

2.15.2 Biopharmaceutical CMO & CRO Type and Applications

2.15.2.1 Product A

2.15.2.2 Product B

2.15.3 WuXi Biologics Biopharmaceutical CMO & CRO Revenue, Gross Margin and Market Share (2016-2017)

3 Global Biopharmaceutical CMO & CRO Market Competition, by Players

3.1 Global Biopharmaceutical CMO & CRO Revenue and Share by Players (2013-2018)

3.2 Market Concentration Rate

3.2.1 Top 5 Biopharmaceutical CMO & CRO Players Market Share

3.2.2 Top 10 Biopharmaceutical CMO & CRO Players Market Share

3.3 Market Competition Trend

4 Global Biopharmaceutical CMO & CRO Market Size by Regions

4.1 Global Biopharmaceutical CMO & CRO Revenue and Market Share by Regions

4.2 North America Biopharmaceutical CMO & CRO Revenue and Growth Rate (2013-2018)

4.3 Europe Biopharmaceutical CMO & CRO Revenue and Growth Rate (2013-2018)

4.4 Asia-Pacific Biopharmaceutical CMO & CRO Revenue and Growth Rate (2013-2018)

4.5 South America Biopharmaceutical CMO & CRO Revenue and Growth Rate (2013-2018)

4.6 Middle East and Africa Biopharmaceutical CMO & CRO Revenue and Growth Rate (2013-2018)

5 North America Biopharmaceutical CMO & CRO Revenue by Countries

5.1 North America Biopharmaceutical CMO & CRO Revenue by Countries (2013-2018)

5.2 USA Biopharmaceutical CMO & CRO Revenue and Growth Rate (2013-2018)

5.3 Canada Biopharmaceutical CMO & CRO Revenue and Growth Rate (2013-2018)

5.4 Mexico Biopharmaceutical CMO & CRO Revenue and Growth Rate (2013-2018)

6 Europe Biopharmaceutical CMO & CRO Revenue by Countries

6.1 Europe Biopharmaceutical CMO & CRO Revenue by Countries (2013-2018)

6.2 Germany Biopharmaceutical CMO & CRO Revenue and Growth Rate (2013-2018)

6.3 UK Biopharmaceutical CMO & CRO Revenue and Growth Rate (2013-2018)

6.4 France Biopharmaceutical CMO & CRO Revenue and Growth Rate (2013-2018)

6.5 Russia Biopharmaceutical CMO & CRO Revenue and Growth Rate (2013-2018)

6.6 Italy Biopharmaceutical CMO & CRO Revenue and Growth Rate (2013-2018)

7 Asia-Pacific Biopharmaceutical CMO & CRO Revenue by Countries

7.1 Asia-Pacific Biopharmaceutical CMO & CRO Revenue by Countries (2013-2018)

7.2 China Biopharmaceutical CMO & CRO Revenue and Growth Rate (2013-2018)

7.3 Japan Biopharmaceutical CMO & CRO Revenue and Growth Rate (2013-2018)

7.4 Korea Biopharmaceutical CMO & CRO Revenue and Growth Rate (2013-2018)

7.5 India Biopharmaceutical CMO & CRO Revenue and Growth Rate (2013-2018)

7.6 Southeast Asia Biopharmaceutical CMO & CRO Revenue and Growth Rate (2013-2018)

8 South America Biopharmaceutical CMO & CRO Revenue by Countries

8.1 South America Biopharmaceutical CMO & CRO Revenue by Countries (2013-2018)

8.2 Brazil Biopharmaceutical CMO & CRO Revenue and Growth Rate (2013-2018)

8.3 Argentina Biopharmaceutical CMO & CRO Revenue and Growth Rate (2013-2018)

8.4 Colombia Biopharmaceutical CMO & CRO Revenue and Growth Rate (2013-2018)

9 Middle East and Africa Revenue Biopharmaceutical CMO & CRO by Countries

9.1 Middle East and Africa Biopharmaceutical CMO & CRO Revenue by Countries (2013-2018)

9.2 Saudi Arabia Biopharmaceutical CMO & CRO Revenue and Growth Rate (2013-2018)

9.3 UAE Biopharmaceutical CMO & CRO Revenue and Growth Rate (2013-2018)

9.4 Egypt Biopharmaceutical CMO & CRO Revenue and Growth Rate (2013-2018)

9.5 Nigeria Biopharmaceutical CMO & CRO Revenue and Growth Rate (2013-2018)

9.6 South Africa Biopharmaceutical CMO & CRO Revenue and Growth Rate (2013-2018)

10 Global Biopharmaceutical CMO & CRO Market Segment by Type

10.1 Global Biopharmaceutical CMO & CRO Revenue and Market Share by Type (2013-2018)

10.2 Global Biopharmaceutical CMO & CRO Market Forecast by Type (2018-2023)

10.3 Mammalian Revenue Growth Rate (2013-2023)

10.4 Non-mammalian Revenue Growth Rate (2013-2023)

11 Global Biopharmaceutical CMO & CRO Market Segment by Application

11.1 Global Biopharmaceutical CMO & CRO Revenue Market Share by Application (2013-2018)

11.2 Biopharmaceutical CMO & CRO Market Forecast by Application (2018-2023)

11.3 Contract Manufacturing Revenue Growth (2013-2018)

11.4 Contract Research Revenue Growth (2013-2018)

12 Global Biopharmaceutical CMO & CRO Market Size Forecast (2018-2023)

12.1 Global Biopharmaceutical CMO & CRO Market Size Forecast (2018-2023)

12.2 Global Biopharmaceutical CMO & CRO Market Forecast by Regions (2018-2023)

12.3 North America Biopharmaceutical CMO & CRO Revenue Market Forecast (2018-2023)

12.4 Europe Biopharmaceutical CMO & CRO Revenue Market Forecast (2018-2023)

12.5 Asia-Pacific Biopharmaceutical CMO & CRO Revenue Market Forecast (2018-2023)

12.6 South America Biopharmaceutical CMO & CRO Revenue Market Forecast (2018-2023)

12.7 Middle East and Africa Biopharmaceutical CMO & CRO Revenue Market Forecast (2018-2023)

13 Research Findings and Conclusion

14 Appendix

14.1 Methodology

14.2 Data Source

List of Tables and Figures

Figure Biopharmaceutical CMO & CRO Picture

Table Product Specifications of Biopharmaceutical CMO & CRO

Table Global Biopharmaceutical CMO & CRO and Revenue (Million USD) Ma

Please fill the form below, to recieve the report sample


+1

Choose License Type

Reach Us

Email us at

sales@mrinsights.biz

Or call us on

US +1-201-465-4211

IND +91-906-779-0957

Why Choose Us

ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems

Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system

Global Outreach6 Major regions and 40+ countries level analysis accomplished

Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery